Abstract
Background/Aim: Preimplantation genetic testing (PGT) for chromosomal screening, based on embryo biopsy, has significant limitations. Cell-free DNA (cf-DNA) has been detected in spent culture medium (SCM), opening new horizons for the development of non-invasive PGT (ni-PGT). In this study, we evaluated the diagnostic performance of ni- PGT for aneuploidy (niPGT-A), comparing the results of trophectoderm biopsies (TE) and respective SCM from individually cultured embryos via Next Generation Sequencing (NGS). Materials and Methods: Forty fresh embryos were analyzed. TE and SCM from blastocysts were collected and analyzed. Results: We detected cfDNA in 100% of samples tested. The overall concordance rate between the ni-PGT-A and PGT-A was 27/33 (81.8%). The full concordance rate was 21/33 (63.6%). The aneuploidy agreement was 91.66%, and the euploidy agreement was 76.19%. Conclusion: We found a good accordance between TE and SCM analysis, suggesting that niPGT-A could be a reliable alternative for chromosomal abnormalities assessment of in vitro cultured embryos.
Author supplied keywords
Cite
CITATION STYLE
Sialakouma, A., Karakasiliotis, I., Ntala, V., Nikolettos, N., & Asimakopoulos, B. (2021). Embryonic cell-free DNA in spent culture medium: A non-invasive tool for aneuploidy screening of the corresponding embryos. In Vivo, 35(6), 3449–3457. https://doi.org/10.21873/invivo.12645
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.